Scientists seek to unlock the Brain's secrets of sight and sound
NCT ID NCT03407066
First seen Jun 25, 2026 · Last updated Sep 09, 2026 · Updated 16 times
Summary
This study aims to understand how healthy brains process what we see and hear. Researchers will use brain scans, eye tracking, and computer tasks to measure perception, memory, and attention. Up to 10,200 participants aged 13-65 with normal vision and hearing will take part online or in person. The goal is to learn more about normal brain function, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 10,200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2019
- Expected to finish
-
Dec 2035
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
For in-lab testing, one hundred subjects (100) will be recruited from a healthy adult population and are expected to represent a broad cross-section of the population. One hundred (100) off-site participants will be recruited for genetic screening. For on-line testing, we anticipate up to 10,000 subjects will be recruited.
- Ages
-
13 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: Inclusion Criteria for In-lab Participants A subject can be included in the in-lab portion of the study if he/she: * is in good general health; * is between 18 and 65 years old; * has visual acuity of 20/40 in at least one eye (corrected with contact lenses is okay); * has no hearing impairment requiring a hearing aid. * is capable of understanding the procedures and requirements of this study; * is willing and able to provide his/her own informed consent. Inclusion Criteria for On-line Participants A subject can be included in the on-line portion of the study if he/she: * is in good general health; * is between 18 and 65 years old; * is capable of understanding the procedures and requirements of this study; * is willing and able to provide his/her own informed consent. Inclusion Criteria for Genetic Screening/Off-site Participants A subject can be included in the off-site portion of the study if he/she: * is between 13 and 65 years old; * is in general good health; * is capable of understanding the procedures and requirements of this study; * is willing and able to provide his/her own informed consent. EXCLUSION CRITERIA: Exclusion Criteria for In-lab Participants A participant is not eligible for participation in the in-lab portion of this study if any of the following exclusion criteria are present, as self-reported by the prospective participant or determined during clinical testing following consent: * Participant is pregnant * Participant has serious vision or hearing problems; for some sub-studies focused on mechanisms of normal color vision, subjects who are colorblind will also be excluded; * Participants without consent capacity will not be enrolled; * Participant has a debilitating neurological disorder (examples include, but are not limited to: brain tumor, epilepsy, Alzheimer's Disease, Parkinson's Disease, multiple sclerosis) or a psychiatric disorder (examples include, but are not limited to: schizophrenia, clinical anxiety, severe depression, attention deficit hyperactivity disorder (ADHD), schizophrenia). Patients with non-debilitating conditions such as prosopagnosia, prosopometamorphosia (PMO), or aphantasia will have their conditions noted but will not be excluded); * Participant has had a serious head injury or has a history of brain surgery. Head injury is defined as an injury to the brain from some external force resulting in loss of consciousness of 30 minutes or more; * Participant has psychoactive drug or alcohol abuse or dependence in the past three months, as determined by the Drug Abuse Screening Test (DAST), except nicotine and caffeine. A score of 6 or greater on the DAST will be considered exclusionary. The effects of nicotine and caffeine in neuroimaging are attenuated if participants do not smoke or consume caffeine 2-3 hours before the scan session; Over-the-counter medication/herbals will not be a criterion for exclusion; * Participant is an NEI employee within the Perception, Cognition and Action section. Additional Exclusion Criteria for MRI Sub-studies Contraindication to MR scanning include the following: metallic tattoos or metallic eyeliner; claustrophobia; inability to lie still on their back for approximately 2 hours; implanted cardiac pacemaker or auto-defibrillator; surgical aneurysm clips; implanted neural stimulator; artificial heart valves or pumps; metal fragments in cranial cavity, body or eyes (e.g., history as a metal worker); nitroglycerin patch (foil backer); cochlear implants (tubes are okay); weight \> 450 lbs; metal rods, plates, screws in body; shrapnel or bullet wound; intrauterine device (IUD) not approved on mrisafety.com (most IUDs are okay); vestibular or inner ear abnormality such as Meniere's disease; metallic braces; hair extensions attached with metallic wires; transdermal patches; movement disorders; dental implants; consumed of nicotine or caffeine in the two hours prior to the experimental session. Subjects may participate in this study but will not be allowed to have a 7.0 T MRI scan if they have metallic dental crowns or a bridge. Exclusion Criteria for Genetic Screening/Off-site Participants Off-site participation will be biased to participants with XY chromosomes until the genetic sequencing capability changes. We do not limit to just XY patients to provide the possibility of evaluating newer genetic sequencing capacity and because sequencing on XX can provide some information, even if it is not as decisive as on XY patients. Exclusion Criteria for On-line Participants Subjects may not participate in the on-line portion of the study if they: * Do not have access to compatible equipment. For example, smartphone screens are too small to be used. The online platform will outline which devices may be used. * Are unwilling to allow permission for JavaScript to run on the site and disable any script blockers. * Are unwilling to agree to the on-line testing platform's terms and conditions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Normal physiology are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Eye Institute (NEI)
RECRUITINGBethesda, Maryland, 20892, United States
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your pupils reveal how light shapes sleep—and why age and sex matter
- Healthy donors needed for research sample bank
- Nicotine's brain impact on depression under the microscope
- Scientists lock volunteers in rooms to measure how many calories they burn after eating
- Brain test could revolutionize alcohol addiction treatment
- Healthy brains scanned twice to test reliability of imaging methods